2015 Antineoplastics


Development of new antineoplastic drugs is extremely complex, and determination of success is significantly different from standards applied to other therapeutics.

First, it is difficult to define exactly what is meant by a "successful chemotherapeutic treatment".

Second, the definition of cancer type is evolving. One of the implications of targeted therapy is that the ultimate definition of a cancer may be unique to each individual patient.

Third, definition of survival rates may not be significant when new treatments make historical survival rates obsolete.

Fourth, for each patient and their family, "it's all or nothing". Success or failure is not a percentage of an individual.

Email: Dr. Janet Fitzakerley | ©2015 University of Minnesota Medical School Duluth | Last modified: 11-apr-15 9:39 AM